AVJ.F American Vanguard Corp
- Market cap
- EUR 21.1M
- P/E
- -
- P/B
- 0.15x
- ROE
- -25.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AVJ.F undervalued?
Graham numberThe Graham number of American Vanguard Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
American Vanguard Corp fundamental analysis
No fundamental analysis for American Vanguard Corp yet.
American Vanguard Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About American Vanguard Corp
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, mo…
Full company profileAmerican Vanguard Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
American Vanguard Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 454M | 456M | 459M | 558M | 610M | 579M | 547M | 515M | 465M |
| Gross Profit | 183M | 173M | 173M | 171M | 192M | 179M | 120M | 148M | 133M |
| Operating Income | 39.0M | 21.6M | 18.3M | 30.8M | 40.7M | 24.3M | -32.0M | 13.8M | -745K |
| EBITDA | 56.1M | 44.4M | 43.5M | 53.1M | 62.1M | 44.7M | -81.6M | -9.99M | 5.84M |
| Net Income | 24.2M | 11.0M | 15.2M | 18.6M | 27.4M | 7.52M | -126M | -49.9M | -42.2M |
| EPS | 0.81 | 0.36 | 0.49 | 0.60 | 0.93 | 0.26 | -4.37 | -1.72 | -1.45 |
| Balance Sheet | |||||||||
| Total Assets | 594M | 670M | 680M | 694M | 726M | 768M | 637M | 597M | 663M |
| Total Liabilities | 264M | 326M | 320M | 321M | 356M | 398M | 404M | 404M | 500M |
| Shareholders' Equity | 329M | 344M | 361M | 373M | 370M | 370M | 233M | 192M | 163M |
| Cash & Short-term Investments | 6.17M | 6.58M | 15.9M | 16.3M | 20.3M | 11.4M | 12.5M | 12.4M | 83.9M |
| Cash Flow | |||||||||
| Operating Cash Flow | 11.3M | 47.2M | 90.3M | 86.4M | 57.1M | -58.7M | 3.92M | -21.2M | -16.5M |
| Capital Expenditure | 27.7M | 12.2M | 15.3M | 10.0M | 14.6M | 12.1M | 7.69M | 4.08M | 13.1M |
| Free Cash Flow | -16.4M | 35.0M | 75.1M | 76.3M | 42.6M | -70.8M | -3.77M | -25.3M | -29.6M |
| Ratios | |||||||||
| ROE | 7.3% | 3.2% | 4.2% | 5.0% | 7.4% | 2.0% | -54.2% | -25.9% | -25.9% |
| ROA | 4.1% | 1.6% | 2.2% | 2.7% | 3.8% | 1.0% | -19.8% | -8.4% | -6.4% |
| Net Profit Margin | 5.3% | 2.4% | 3.3% | 3.3% | 4.5% | 1.3% | -23.1% | -9.7% | -9.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
American Vanguard Corp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 26, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | USD 2.51M | 0.09 | - |
| 2023 | USD 3.38M | 0.12 | 45.0% |
| 2022 | USD 2.79M | 0.09 | 10.2% |
| 2021 | USD 2.38M | 0.08 | 12.8% |
| 2020 | USD 1.17M | 0.04 | 7.7% |
| 2019 | USD 2.33M | 0.08 | 21.2% |
| 2018 | USD 2.20M | 0.07 | 9.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns American Vanguard Corp
- Insiders 6.70%
- Institutions 55.01%
- Public & others 38.29%
- Shares outstanding 29.6M
- Free float 28.4M
American Vanguard Corp company profile
- Company name
- American Vanguard Corp
- Ticker
- AVJ.F
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Employees
- 739
- Fiscal year end
- December
- Address
- 4695 MacArthur Court, Newport Beach, CA, United States, 92660
- Phone
- 949 260 1200
- Website
- american-vanguard.com
About American Vanguard Corp
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
American Vanguard Corp management
10- Mr. Douglas A. Kaye IIIChairman & CEO · born 1969
- Mr. David T. Johnson C.F.A.Chief Accounting Officer · born 1957
- Mr. Timothy J. Donnelly Esq.Chief Information Officer, General Counsel & Secretary · born 1960
- Ms. Shirin KhosraviChief Human Resource Officer · born 1969
- Mr. Shayne M. WetherallChief Executive Officer of Specialty Business · born 1966
- Mr. Matthew HorwathChief Financial Officer · born 1984
- Mr. Jared StanleySenior Vice President of Supply Chain & Operations
- Mr. Anthony Young C.F.A.Director of Investor Relations
- Mr. William A. KuserDirector of Corporate Communications
- Mr. Michael J. DiPaolaChief Commercial Officer